These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19710104)

  • 1. Interleukin-6 is associated with liver lipid homeostasis but not with cell death in experimental hepatic steatosis.
    Sánchez-Garrido MA; Chico Y; González R; Ranchal I; González-Rubio S; Hidalgo AB; Díaz-López C; Costán G; Padillo FJ; De la Mata M; Ochoa B; Muntané J
    Innate Immun; 2009 Dec; 15(6):337-49. PubMed ID: 19710104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease.
    Hong F; Radaeva S; Pan HN; Tian Z; Veech R; Gao B
    Hepatology; 2004 Oct; 40(4):933-41. PubMed ID: 15382116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe steatosis increases hepatocellular injury and impairs liver regeneration in a rat model of partial hepatectomy.
    Veteläinen R; van Vliet AK; van Gulik TM
    Ann Surg; 2007 Jan; 245(1):44-50. PubMed ID: 17197964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
    Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
    Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis.
    Li Z; Agellon LB; Allen TM; Umeda M; Jewell L; Mason A; Vance DE
    Cell Metab; 2006 May; 3(5):321-31. PubMed ID: 16679290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting cholesterol at different levels in the mevalonate pathway protects fatty liver against ischemia-reperfusion injury.
    Llacuna L; Fernández A; Montfort CV; Matías N; Martínez L; Caballero F; Rimola A; Elena M; Morales A; Fernández-Checa JC; García-Ruiz C
    J Hepatol; 2011 May; 54(5):1002-10. PubMed ID: 21145825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steatotic liver allografts up-regulate UCP-2 expression and suffer necrosis in rats.
    Uchino S; Yamaguchi Y; Furuhashi T; Wang FS; Zhang JL; Okabe K; Kihara S; Yamada S; Mori K; Ogawa M
    J Surg Res; 2004 Jul; 120(1):73-82. PubMed ID: 15172192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial adaptations to steatohepatitis induced by a methionine- and choline-deficient diet.
    Romestaing C; Piquet MA; Letexier D; Rey B; Mourier A; Servais S; Belouze M; Rouleau V; Dautresme M; Ollivier I; Favier R; Rigoulet M; Duchamp C; Sibille B
    Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E110-9. PubMed ID: 17986629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphatidylcholine protects against steatosis in mice but not non-alcoholic steatohepatitis.
    Niebergall LJ; Jacobs RL; Chaba T; Vance DE
    Biochim Biophys Acta; 2011 Dec; 1811(12):1177-85. PubMed ID: 21745592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of mitochondrial glutathione-dependent hepatocellular susceptibility to TNF despite NF-kappaB activation.
    Marí M; Colell A; Morales A; Caballero F; Moles A; Fernández A; Terrones O; Basañez G; Antonsson B; García-Ruiz C; Fernández-Checa JC
    Gastroenterology; 2008 May; 134(5):1507-20. PubMed ID: 18343380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phyllanthus urinaria ameliorates the severity of nutritional steatohepatitis both in vitro and in vivo.
    Shen B; Yu J; Wang S; Chu ES; Wong VW; Zhou X; Lin G; Sung JJ; Chan HL
    Hepatology; 2008 Feb; 47(2):473-83. PubMed ID: 18157836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of hepatic steatosis by omega-3 fatty acids measured non-invasively by (1) H-magnetic resonance spectroscopy in a rat model.
    Marsman HA; Heger M; Kloek JJ; Nienhuis SL; van Werven JR; Nederveen AJ; Ten Kate FJ; Stoker J; van Gulik TM
    J Gastroenterol Hepatol; 2011 Feb; 26(2):356-63. PubMed ID: 21261727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease.
    Ganji SH; Kukes GD; Lambrecht N; Kashyap ML; Kamanna VS
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G320-7. PubMed ID: 24356885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis.
    Kitamura K; Tada S; Nakamoto N; Toda K; Horikawa H; Kurita S; Tsunematsu S; Kumagai N; Ishii H; Saito H; Hibi T
    J Gastroenterol Hepatol; 2007 Nov; 22(11):2022-33. PubMed ID: 17914985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pro-inflammatory action of tumour necrosis factor-α in non-alcoholic steatohepatitis is independent of the NSMAF gene product.
    Mas E; Danjoux M; Garcia V; Carpentier S; Ségui B; Levade T
    Dig Liver Dis; 2013 Feb; 45(2):147-54. PubMed ID: 23044079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial glutathione: hepatocellular survival-death switch.
    Garcia-Ruiz C; Fernandez-Checa JC
    J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3():S3-6. PubMed ID: 16958667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased susceptibility of fat-laden Zucker-rat hepatocytes to bile acid-induced oncotic necrosis: an in vitro model of steatocholestasis.
    Kobak GE; Dahl R; Devereaux MW; Gumpricht E; Traber M; Doctor RB; Sokol RJ
    J Lab Clin Med; 2005 May; 145(5):247-62. PubMed ID: 15902097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibitors improve hepatic steatosis by modulating expression of tumour necrosis factor-alpha, interleukin-6 and adiponectin receptor-2 in rats with type 2 diabetes.
    Zhang X; Li ZZ; Liu DF; Xu X; Mei ZC; Shen W
    Clin Exp Pharmacol Physiol; 2009 Jul; 36(7):631-6. PubMed ID: 19076162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor-alpha accelerates apoptosis of steatotic hepatocytes from a murine model of non-alcoholic fatty liver disease.
    Zhang W; Kudo H; Kawai K; Fujisaka S; Usui I; Sugiyama T; Tsukada K; Chen N; Takahara T
    Biochem Biophys Res Commun; 2010 Jan; 391(4):1731-6. PubMed ID: 20043871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.